4 May 2017
Researchers from the Royal Brompton & Harefield NHS Foundation Trust recently took part in a major networking event aimed at fostering future collaborations between industry and leading academic institutions in London and the South East.
Organised by MedCity and held at the Wellcome Collection in Euston, London, earlier in the year, the event attracted more than 170 representatives from over 50 technology and pharmaceutical companies.
Attendees were able to find out more about how biomedical research expertise in the region is making a difference to patient care – with an eye on potentially forging new research partnerships.
Event participants met Trust researchers to discuss their expertise in the following areas:
- cutting-edge imaging techniques in cardiovascular magnetic resonance in heart muscle disease diagnosis
- world class novel therapies including gene therapy in cystic fibrosis and bronchoscopy for emphysema
- state of the art clinical genetics and genomics facilities; and research expertise – in diagnosing respiratory and cardiovascular disease
- advanced information platforms to enable researchers to fully explore research problems using Big Data
Geraldine Sloane, cardiovascular research manager, said: “The event was extremely relevant to research expertise at the Trust. It provided a great opportunity for face-to-face discussions on what we can offer industry partners that has led to a number of new contacts. We found it very fruitful and look forward to participating in future networking opportunities organised by MedCity.”
Royal Brompton’s involvement in the MedCity network is also strengthened through a project grant from MedCity’s £2 million ‘Collaborate to Innovate’ programme, in collaboration with Imperial College London and the start-up company, Optellum, designed to commercialise life science discoveries.
If you are interested in finding out more about possible partnerships, or funding our vital research, please email firstname.lastname@example.org.